Results
4397
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
4,397 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
589 | HK$0.19 | 0% | -32.1% | HK$118.8m | n/a | PS0.3x | n/a | 0% | ||
AVER | ₪9.54 | -5.6% | -31.2% | ₪67.0m | n/a | PS3.8x | n/a | 0% | ||
NXH | CA$1.00 | 7.5% | 31.6% | CA$18.6m | n/a | PS11.1x | n/a | n/a | ||
MDA | CA$24.35 | 0.4% | 70.4% | CA$3.0b | CA$32.56 | PE43.7x | E33.9% | n/a | ||
APWC | US$1.53 | -12.8% | 18.6% | US$32.3m | n/a | PE8.6x | n/a | 0% | ||
JCSE | US$1.28 | -14.1% | 66.9% | US$8.2m | n/a | PE10.9x | n/a | 14.0% | ||
ILAG | US$0.83 | 3.9% | 43.1% | US$15.0m | n/a | PS1.7x | n/a | n/a | ||
MRCY | US$42.39 | -4.6% | 47.4% | US$2.5b | US$43.63 | PS2.9x | E96.5% | n/a | ||
HY | US$50.61 | -4.2% | -27.4% | US$910.6m | US$72.50 | PE5.6x | E-38.9% | 2.8% | ||
BGLC | US$0.36 | -3.1% | -52.1% | US$6.3m | n/a | PS0.7x | n/a | n/a | ||
HWM | US$129.56 | -2.9% | 96.7% | US$52.6b | US$139.86 | PE45.5x | E15.5% | 0.3% | ||
ELJ | RON 0.19 | 9.4% | -7.0% | RON 8.7m | n/a | PS0.8x | n/a | n/a | ||
CME | RM 0.01 | 0% | -60.0% | RM 12.1m | n/a | PS0.4x | n/a | n/a | ||
ITW | US$261.60 | 1.4% | 0.7% | US$77.6b | US$263.37 | PE22x | E1.9% | 2.3% | ||
APL | zł1.19 | 0% | 10.2% | zł3.9m | n/a | PE3.4x | n/a | n/a | ||
BWXT | US$99.90 | -6.5% | 11.1% | US$9.3b | US$139.00 | PE33x | E10.1% | 1.0% | ||
APOG | US$48.48 | -2.2% | -14.3% | US$1.1b | US$66.00 | PE10.8x | E1.5% | 2.1% | ||
AGP | zł4.18 | -0.5% | -5.0% | zł10.6m | n/a | PS1.8x | n/a | n/a | ||
3305 | NT$68.90 | -0.3% | -5.5% | NT$9.1b | n/a | PE24.8x | n/a | 2.9% | ||
HCL | AU$0.17 | 3.0% | 17.2% | AU$17.5m | AU$0.35 | PS0.4x | E106.0% | n/a | ||
000065 | CN¥12.15 | 11.6% | 8.5% | CN¥12.5b | CN¥13.00 | PE12.6x | E9.3% | 0.8% | ||
7792 | NT$165.00 | 1.2% | n/a | NT$7.0b | n/a | PE19.5x | n/a | n/a | ||
STCL | PK₨13.50 | -1.7% | 11.1% | PK₨3.2b | n/a | PS0.2x | n/a | 5.6% | ||
ADRS | €86.00 | -1.1% | 4.9% | €1.2b | €76.10 | PE20.4x | E20.5% | 3.0% |